Next, we performed multivariate analysis using Cox proportional hazards model to assess the independent prognostic relevance of DNA-PKcs expression adjusted for clinicopathological variables (age, tumor size, histological grade, axillary lymph node status), breast cancer subtypes, and systemic treatments. This evidence concerns the gene PRKDC and breast carcinoma.